PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
HIV Seropositivity D006679 15 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Chondrosarcoma D002813 9 associated lipids
Dirofilariasis D004184 3 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Hypothermia D007035 19 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Parkinson Disease D010300 53 associated lipids
Down Syndrome D004314 18 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Narumiya S and Fukushima M Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. 1986 J. Pharmacol. Exp. Ther. pmid:3772804
Narumiya S et al. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. 1986 J. Pharmacol. Exp. Ther. pmid:3772805
Cooper B Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis. 1979 Blood pmid:380688
Kasukabe T et al. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1. 1985 Biochim. Biophys. Acta pmid:3855662
Narumiya S and Fukushima M delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. 1985 Biochem. Biophys. Res. Commun. pmid:3857041
Abbate R et al. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia. 1985 Atherosclerosis pmid:3857047
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Arisawa M et al. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary. 1985 Asia Oceania J Obstet Gynaecol pmid:3860198
Weinreb RN et al. Prostanoids in rabbit aqueous humor: effect of laser photocoagulation of the iris. 1985 Invest. Ophthalmol. Vis. Sci. pmid:3860488
Spannhake EW et al. Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. 1985 J. Pharmacol. Exp. Ther. pmid:3860642
Nielsen JA and Sparber SB Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. 1985 Pharmacol. Biochem. Behav. pmid:3860881
Liston TE and Roberts LJ Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. 1985 Proc. Natl. Acad. Sci. U.S.A. pmid:3862115
Costall B et al. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. 1985 Br. J. Pharmacol. pmid:3862460
Tanaka H et al. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells. 1985 Prostaglandins pmid:3863195
Liston TE and Roberts LJ Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. 1985 J. Biol. Chem. pmid:3863815
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819
Roberts LJ and Sweetman BJ Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis. 1985 Prostaglandins pmid:3864190
Bhattacharya SK et al. Prostaglandin D2 mediated specific increase in rat brain serotonin. 1985 Proc. West. Pharmacol. Soc. pmid:3865228
Walenga RW et al. Re-examination of the assay for plasma prostanoids by solid-phase extraction, and radioimmunoassay. 1985 Prostaglandins Leukot Med pmid:3865240
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724
Okuyama S et al. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2. 1985 Ann. N. Y. Acad. Sci. pmid:3868328
Okuyama S and Mishina H Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870142
Okuyama S and Mishina H Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870143
Murray JJ et al. Prostaglandin D2 is released during acute allergic bronchospasm in man. 1985 Trans. Assoc. Am. Physicians pmid:3870298
Hall TJ et al. Decreased natural killer cell activity in atopic eczema. 1985 Immunology pmid:3876984
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
Korbut R and Gryglewski RJ Anti-aggregatory prostanoids. Part I. 1985 Sep-Dec Acta Physiol Pol pmid:3915631
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Thompson NT and Scrutton MC Intracellular calcium fluxes in human platelets. 1985 Eur. J. Biochem. pmid:3918866
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Beatty CH et al. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. 1985 Atherosclerosis pmid:3924062
Nolan PN et al. Participation of prostanoids in chemical activation of the pericardial pressor reflex in dogs. 1985 Jan-Feb Clin. Exp. Pharmacol. Physiol. pmid:3924453
Campbell WB and Gomez-Sanchez CE Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells. 1985 Endocrinology pmid:3924581
Ueno R et al. Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging. 1985 J. Neurochem. pmid:3925085
Lewis RA and Robin JL Arachidonic acid derivatives as mediators of asthma. 1985 J. Allergy Clin. Immunol. pmid:3926852
Baud L et al. Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro. 1985 Kidney Int. pmid:3927056
Urade Y et al. Purification and characterization of rat brain prostaglandin D synthetase. 1985 J. Biol. Chem. pmid:3930495
Schick B and Austen KF Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1985 Immunology pmid:3935569
Orchard MA et al. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma. 1985 Thromb. Res. pmid:3936223
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
McGuire JC et al. Production of prostaglandin D2 by murine macrophage cell lines. 1985 Prostaglandins pmid:3937182
Tynan SS et al. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. 1984 Prostaglandins pmid:6087417
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860